Ginkgo Bioworks
Ginkgo Bioworks is an American biotech company founded in 2009 by scientists from MIT and headed by Tom Knight. The company specializes in using genetic engineering to produce bacteria with industrial applications.[1][2][3][4] Ginkgo Bioworks is an analytics company that designs organisms for customers in a range of industries. It is the self-proclaimed "Organism Company" and is one of the world's largest privately held biotech companies.[5] As of 2019, it was valued at $4.2 billion.[6]
| Type | Private |
|---|---|
| Industry | Biotechnology |
| Founded | 2009 in Boston, Massachusetts, United States of America |
| Founders | Tom Knight, Jason Kelly, Reshma Shetty, Barry Canton, Austin Che |
| Headquarters | , |
Key people | Tom Knight Jason Kelly Reshma Shetty Barry Canton Austin Che Christina Agapakis, Creative Director |
Number of employees | ~200 |
| Website | ginkgobioworks |
Funding
In 2019, Ginkgo Bioworks received $290 million in September and a $350 million fund in October. [5]
References
- Molteni, Megan (14 September 2017). "With Designer Bacteria, Crops One Day Could Fertilize Themselves". Wired. Retrieved 4 December 2017.
- Herper, Mathew (8 June 2016). "Boston Startup Raises $100 Million To Use Synthetic Biology To Design Microbes For Industry". Forbes. Retrieved 4 December 2017.
- Adams, Susan (14 September 2017). "Bayer And Ginkgo Bioworks, A Startup, Aim To Make Crops Produce Their Own Nitrogen Fertilizer". Forbes. Retrieved 4 December 2017.
- Weisman, Robert (29 September 2016). "Ginkgo Bioworks opens production site for custom cells". Boston Globe. Retrieved 4 December 2017.
- "Ginkgo Bioworks raises $350 million fund for biotech spinouts". Reuters. 2019-10-09. Retrieved 2019-11-07.
- "Ginkgo Bioworks CEO Wants Biology to Manufacture Physical Goods". Bloomberg. Retrieved 2019-11-07.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.